enow.com Web Search

  1. Ads

    related to: day after tysabri infusion for prostate cancer

Search results

  1. Results from the WOW.Com Content Network
  2. EPOCH (chemotherapy) - Wikipedia

    en.wikipedia.org/wiki/EPOCH_(chemotherapy)

    Days Rituximab: 375 mg/m 2: IV infusion: Day 1 Etoposide: 50 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Prednisolone: 60 mg/m 2: By mouth, twice a day (PO BID) Days 1–5 Oncovin: vincristine: 0.4 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Cyclophosphamide: 750 mg/m 2: IV bolus given over 15 min: Day 5 Hydroxydaunorubicin ...

  3. Natalizumab - Wikipedia

    en.wikipedia.org/wiki/Natalizumab

    Natalizumab, sold under the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. [9] It is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin . [ 9 ]

  4. Management of prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Management_of_prostate_cancer

    Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.

  5. New TYSABRI® Data Show Earlier Treatment and Longer ... - AOL

    www.aol.com/news/2013-10-03-new-tysabri-data...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Shannen Doherty says 'miracle' cancer infusion has given her ...

    www.aol.com/news/shannen-doherty-says-miracle...

    The cancer spread to her brain and bones in 2023. "Every day is a gift, and there are so many new things in the works that I think hope is always there," Doherty said on her podcast.

  7. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology (immuno-oncology) and a growing subspecialty of oncology.

  1. Ads

    related to: day after tysabri infusion for prostate cancer